GPT and metabolic dysfunction-associated steatohepatitis: The plasma activities of ALT and AST, indicators of liver damage, were reduced in the YC-1102- and OCA-treated groups, indicating that YC-1102 effectively prevents FPC diet-induced NASH injuries, similarly to OCA [Figure 1D].